-
公开(公告)号:US11963773B2
公开(公告)日:2024-04-23
申请号:US17547040
申请日:2021-12-09
申请人: TheraNova, LLC
发明人: Daniel R. Burnett
IPC分类号: A61B5/00 , A61B5/01 , A61B5/02 , A61B5/0205 , A61B5/0215 , A61B5/11 , A61B5/145 , A61B5/16 , A61B5/20 , A61B5/318 , A61B5/392 , A61M25/00 , A61M25/04 , A61B5/024 , A61B5/026 , A61B5/029 , A61B5/08 , A61B5/369 , A61B10/00
CPC分类号: A61B5/205 , A61B5/0059 , A61B5/01 , A61B5/02 , A61B5/0205 , A61B5/0215 , A61B5/1112 , A61B5/14532 , A61B5/14539 , A61B5/14546 , A61B5/16 , A61B5/207 , A61B5/318 , A61B5/392 , A61B5/6852 , A61B5/6853 , A61B5/7278 , A61M25/0017 , A61M25/04 , A61B5/024 , A61B5/0261 , A61B5/029 , A61B5/0816 , A61B5/369 , A61B5/4839 , A61B10/007 , A61B2562/0247 , A61M2025/0003
摘要: Foley type catheter embodiments for sensing physiologic data from a urinary tract of a patient are disclosed. The system includes the catheter and a data processing apparatus and methods for sensing physiologic data from the urinary tract. Embodiments may also include a pressure sensor having a pressure interface at a distal end of the catheter, a pressure transducer at a proximal end, and a fluid column disposed between the pressure interface and transducer. When the distal end is residing in the bladder, the pressure transducer can transduce pressure impinging on it into a chronological pressure profile, which can be processed by the data processing apparatus into one or more distinct physiologic pressure profiles, for example, peritoneal pressure, respiratory rate, and cardiac rate. At a sufficiently high data-sampling rate, these physiologic data may further include relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
-
公开(公告)号:US11800992B2
公开(公告)日:2023-10-31
申请号:US15993483
申请日:2018-05-30
申请人: TheraNova, LLC
发明人: Daniel R. Burnett
IPC分类号: A61B5/06 , A61M1/28 , A61M5/142 , A61M5/172 , A61B5/20 , A61F7/12 , A61F7/00 , A61B5/00 , A61B5/0205 , A61M25/01 , A61B5/318 , A61B5/024 , A61B5/145
CPC分类号: A61B5/068 , A61B5/0022 , A61B5/02055 , A61B5/207 , A61B5/208 , A61F7/0085 , A61F7/12 , A61M1/28 , A61M5/142 , A61M5/1723 , A61B5/024 , A61B5/14507 , A61B5/318 , A61F2007/0022 , A61F2007/0063 , A61F2007/0093 , A61F2007/126 , A61M2025/0166 , A61M2205/3303 , A61M2230/04 , A61M2230/10 , A61M2230/202 , A61M2230/205 , A61M2230/208 , A61M2230/65
摘要: An automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient. The invention also includes a method of controlling infusion of a fluid to a patient. The method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
-
公开(公告)号:US11446177B2
公开(公告)日:2022-09-20
申请号:US17702717
申请日:2022-03-23
申请人: TheraNova, LLC
发明人: Daniel R. Burnett , Shane Mangrum
摘要: Embodiments of the invention provide apparatus, systems and method for introducing fluids into a body cavity for treatment. One embodiment provides an apparatus for treating a patient including an access device for insertion into the peritoneal cavity of the patient including an infusion member in a lumen of the access device. An oxygenated solution may be infused and removed into and out of the cavity via the infusion member.
-
公开(公告)号:US11026824B2
公开(公告)日:2021-06-08
申请号:US16239305
申请日:2019-01-03
申请人: TheraNova, LLC
发明人: Daniel R. Burnett , Shane Mangrum , Timothy Tigner , Evan S. Luxon , Marcie Hamilton , Alex Yee , Jose Gutierrez
摘要: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.
-
公开(公告)号:US11672981B2
公开(公告)日:2023-06-13
申请号:US16823767
申请日:2020-03-19
申请人: TheraNova, LLC
IPC分类号: A61N1/36 , A61B5/02 , A61B5/0531 , A61B5/11 , A61B5/00
CPC分类号: A61N1/36028 , A61N1/36031 , A61N1/36034 , A61B5/02 , A61B5/0531 , A61B5/1101 , A61B5/4266 , A61B2562/0219
摘要: Methods and devices for treating and managing addiction are disclosed where an apparatus for mitigating addictive behavior may generally comprise at least two electrodes for positioning in proximity to an ulnar nerve of a body of a subject and one or more sensors configured to detect physiologic parameters which correlate to one or more symptoms indicative of addictive behavior of the subject. A pulse generator may be programmed to receive a sensor output based on the detected physiologic parameters and to apply a treatment stimulation to the ulnar nerve through a skin surface of the subject such that the addictive behavior of the subject is reduced.
-
公开(公告)号:US09928586B2
公开(公告)日:2018-03-27
申请号:US14935259
申请日:2015-11-06
申请人: TheraNova, LLC
CPC分类号: G06T7/0012 , G06F19/00 , G06F19/321 , G06F19/3418 , G06T7/62 , G06T2207/30108 , G06T2210/41 , G16H30/20 , G16H50/20 , G16H50/30 , G16H80/00
摘要: A computer application on a device for tracking menstrual blood loss by receiving an image of a used sanitary product, analyzing, or receiving analysis of, the amount of blood volume in the image, and aggregating the blood volume from more than one image to determine total blood loss volume for a menstrual cycle.
-
公开(公告)号:US11241179B2
公开(公告)日:2022-02-08
申请号:US15063377
申请日:2016-03-07
申请人: TheraNova, LLC
发明人: Daniel R. Burnett
IPC分类号: A61B5/00 , A61B5/20 , A61B5/02 , A61B5/0215 , A61M25/04 , A61B5/318 , A61B5/392 , A61M25/00 , A61B5/01 , A61B5/0205 , A61B5/11 , A61B5/145 , A61B5/16 , A61B5/024 , A61B5/029 , A61B5/08 , A61B10/00 , A61B5/369 , A61B5/026
摘要: Foley type catheter embodiments for sensing physiologic data from a urinary tract of a patient are disclosed. The system includes the catheter and a data processing apparatus and methods for sensing physiologic data from the urinary tract. Embodiments may also include a pressure sensor having a pressure interface at a distal end of the catheter, a pressure transducer at a proximal end, and a fluid column disposed between the pressure interface and transducer. When the distal end is residing in the bladder, the pressure transducer can transduce pressure impinging on it into a chronological pressure profile, which can be processed by the data processing apparatus into one or more distinct physiologic pressure profiles, for example, peritoneal pressure, respiratory rate, and cardiac rate. At a sufficiently high data-sampling rate, these physiologic data may further include relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
-
公开(公告)号:US11219542B2
公开(公告)日:2022-01-11
申请号:US17093453
申请日:2020-11-09
申请人: TheraNova, LLC
发明人: Daniel R. Burnett , Shane Mangrum , Timothy Tigner , Evan S. Luxon , Marcie Hamilton , Alex Yee , Jose Gutierrez
摘要: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.
-
公开(公告)号:US10143408B2
公开(公告)日:2018-12-04
申请号:US15451155
申请日:2017-03-06
申请人: TheraNova, LLC
IPC分类号: A61B5/00 , A61B5/145 , A61M5/172 , A61B5/1459 , A61B5/1473 , A61B5/1486 , A61M1/28 , A61M5/142 , A61M5/14
摘要: Methods and devices for the diagnosis and treatment of diabetes are disclosed in which an analyte concentration within a peritoneal fluid of a human subject may be determined by implanting an analyte sensor apparatus in the subject where the apparatus may comprise a housing and a flexible sensing catheter which has a lumen with a plurality of apertures and an exterior surface with an analyte sensor affixed thereto. The catheter may comprise a proximal end attached to the housing and the remaining end may be positioned freely within the peritoneal space to contact peritoneal fluid where an analyte concentration in the peritoneal fluid may be sensed. The housing may be anchored at a subcutaneous site proximate the peritoneal space. The sensed analyte concentration may then be transduced into a transmittable electrical signal.
-
公开(公告)号:US11284832B2
公开(公告)日:2022-03-29
申请号:US15222670
申请日:2016-07-28
申请人: TheraNova, LLC
IPC分类号: A61B5/00 , A61B1/273 , A61B5/01 , A61B5/03 , A61B5/107 , A61B5/145 , A61J15/00 , A23L35/00 , A23L33/00
摘要: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.
-
-
-
-
-
-
-
-
-